Global Cord Blood Corporation

Class Action Complaint in MW Gestion, described as "an institutional asset manager based in France" v. Global Cord Blood Corporation, described as a Cayman Islands-domiciled, Hong Kong-based company that "provides umbilical cord blood storage and ancillary services in the in the Beijing Municipality, Guangdong Province, and Zhejiang Province of the People’s Republic of China"; Ting Zheng, Bing Chuen, a.k.a. Albert Chen; Yuen Kam, Mark Da-Jian Chen, Jennifer J. Weng, Ken Lu, Jack Chow, Jacky Cheng, Golden Meditech Holdings Limited, of the Cayman Islands; Golden Meditech Stem Cells (BVI) Company Limited, of the British Virgin Islands; GM Precision Medicine (BVI) Limited, of the British Virgin Islands; Golden Meditech Precision Medicine Limited, of Hong Kong; Golden Meditech (BVI) Company Limited, of the British Virgin Islands, and KPMG Huazhen LLP at the U.S. District Court for the Southern District of New York.

Complaint "to recoup the substantial funds - at least hundreds of millions of dollars - that insiders brazenly stole from Global Cord Blood" in MW Gestion and MW Optimum, derivatively and on behalf of nominal defendant Global Cord Blood Corporation, of the Cayman Islands v. Golden Meditech Holdings Limited, of the Cayman Islands; Ting (Tina) Zheng, Albert Chen, Yuen Kam, Mark Da-Jian Chen, Jennifer J. Weng, Ken Lu, Jack Chow, Jacky Cheng, all of Hong Kong; Celenkos Inc., of Delaware; Golden Meditech Stem Cells (BVI) Company Limited, GM Precision Medicine (BVI) Limited, of the British Virgin Islands; Golden Meditech (BVI) Company Limited, all of the British Virgin Islands; Easton Capital Corp., and Redwood Valuation Partners, both of New York, USA, at the Supreme Court of the State of New York, County of New York.

Chapter 15 Petition for Recognition of a Foreign Main Proceeding in the Cayman Islands by Margot MacInnis, John Royle, and Chow Tsz Nga Georgia, as the Foreign Representatives of Global Cord Blood Corporation, described as "a holding company that wholly owns certain companies that conduct the business of storing umbilical cord blood, mainly to enable parents to preserve their children’s stem cells", filed at the U.S. Bankruptcy Court for the Southern District of New York.

Application by Blue Ocean Structure Investment Company Ltd. to take discovery from Simrit Pamar, ROCELO LLC, and Cellenkos Inc. for use in legal proceedings in the Cayman Islands involving Global Cord Blood Corporation, described as a Cayman Islands-domiciled, Hong Kong-based, New York Stock Exchange-listed company whose "main business is the storage of umbilical cord blood stem cells, principally in the People’s Republic of China", filed at the U.S. District Court for the Southern District of Texas.

Writ of Summons in Blue Ocean Structure Investment Company Limited, of the British Virgin Islands v. Global Cord Blood Corporation. of the Cayman Islands; Tina Ting Zheng, Albert Bing Chuen Chen, Mark D. Chen, Jack Chow, Ken Lu, Jennifer J. Weng, Jacky Siu Chuen Cheng, Kam Yuen, PAGAC III Holding VII Limited, and GM Precision Medicine (BVI) Limited, all described as being based in Hong Kong, at the Grand Court of the Cayman Islands.

Winding Up Petition in Blue Ocean Structure Investment Company Limited v. Global Cord Blood Corporation, described as a Hong Kong-based company that "carries on the business of the storage of umbilical cord blood stem cells principally in the People's Republic of China", at the Grand Court of the Cayman Islands.

Stop Notice by Blue Ocean Structure Investment Company Ltd. regarding shares in Global Cord Blood Corporation at the Grand Court of the Cayman Islands.

Originating Summons in Jayhawk Capital Management LLC, JHMS Fund LLC, and Kent C. McCarthy, all of Kansas, v. Global Cord Blood Corporation, a Cayman Islands company based in Hong Kong whose shares are listed on the New York Stock Exchange; Mark D. Chen, of New York; Jennifer Weng, of New York, and Ken Lu, of Hong Kong, at the Grand Court of the Cayman Islands.